|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Autier P, Boniol M, La Vecchia C, Vatten
L, Gavin A, Héry C and Heanue M: Disparities in breast cancer
mortality trends between 30 European countries: Retrospective trend
analysis of WHO mortality database. BMJ. 341:(aug11 1): c36202010.
View Article : Google Scholar
|
|
4
|
Doll R, Payne P and Waterhouse JAH: Cancer
Incidence in Five Continents. I:Geneva: Union Internationale Contre
le Cancer. 1966. View Article : Google Scholar
|
|
5
|
Lacroix M: Significance, detection and
markers of disseminated breast cancer cells. Endocr Relat Cancer.
13:1033–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saini KS, Taylor C, Ramirez AJ, Palmieri
C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O,
Skrzypski M, et al: Role of the multidisciplinary team in breast
cancer management: Results from a large international survey
involving 39 countries. Ann Oncol. 23:853–859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu W, Sun M, Zou GM and Chen J: MicroRNA
and cancer: Current status and prospective. Int J Cancer.
120:953–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A MicroRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu SL, Chen HY, Chang GC, Chen CY, Chen
HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yousef M, Showe L and Showe M: A study of
microRNAs in silico and in vivo: Bioinformatics
approaches to microRNA discovery and target identification. FEBS J.
2762150:21562009.Liu CG, Calin GA, Volinia S and Croce CM: MicroRNA
expression profiling using microarrays. Nat Protoc 3: 563-578,
2008.
|
|
15
|
Liu CG, Calin GA, Volinia S and Croce CM:
MicroRNA expression profiling using microarrays. Nat Protoc.
3:563–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dvinge H, Git A, Gräf S, Salmon-Divon M,
Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA, et al:
The shaping and functional consequences of the microRNA landscape
in breast cancer. Nature. 497:378–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li LC, Okino ST, Zhao H, Pookot D, Place
RF, Urakami S, Enokida H and Dahiya R: Small dsRNAs induce
transcriptional activation in human cells. Proc Natl Acad Sci USA.
103:17337–17342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morris KV, Chan SW, Jacobsen SE and Looney
DJ: Small interfering RNA-induced transcriptional gene silencing in
human cells. Science. 305:1289–1292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho WC: MicroRNAs: Potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Redell JB, Liu Y and Dash PK: Traumatic
brain injury alters expression of hippocampal microRNAs: potential
regulators of multiple pathophysiological processes. J Neurosci
Res. 87:1435–1448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang K, Zhang S, Marzolf B, Troisch P,
Brightman A, Hu Z, Hood LE and Galas DJ: Circulating microRNAs,
potential biomarkers for drug-induced liver injury. Proc Natl Acad
Sci USA. 106:4402–4407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao N, Yu H, Sun M, Zhang Y, Xu M and Gao
W: MiRNA-711-SP1-collagen-I pathway is involved in the
anti-fibrotic effect of pioglitazone in myocardial infarction. Sci
China Life Sci. 56:431–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
American Joint Committee on Cancer: Cancer
Staging Manual. Greene FL, Page DL, Fleming ID and Fritz AG: (6th).
(New York, NY). Springer Science+Business Media. 221–240. 2002.
|
|
26
|
Körbler T, Grsković M, Dominis M and
Antica M: A simple method for RNA isolation from formalin-fixed and
paraffin-embedded lymphatic tissues. Exp Mol Pathol. 74:336–340.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rivas MA, Venturutti L, Huang YW,
Schillaci R, Huang TH and Elizalde PV: Downregulation of the
tumor-suppressor miR-16 via progestin-mediated oncogenic signaling
contributes to breast cancer development. Breast Cancer Res.
14:R772012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sabirzhanov B, Stoica BA, Zhao Z, Loane
DJ, Wu J, Dorsey SG and Faden AI: miR-711 upregulation induces
neuronal cell death after traumatic brain injury. Cell Death
Differ. Oct 16–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ralfkiaer U, Hagedorn PH, Bangsgaard N,
Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT,
Lauenborg B, Zibert JR, et al: Diagnostic microRNA profiling in
cutaneous T-cell lymphoma (CTCL). Blood. 118:5891–5900. 2011.
View Article : Google Scholar : PubMed/NCBI
|
